Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer.

Saved in:
Bibliographic Details
Title: Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer.
Authors: Philipson RG; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA., Romero T; UCLA Division of General Internal Medicine and Health Services Research, Los Angeles, CA, USA., Wong JK; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Stish BJ; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA., Dess RT; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA., Spratt DE; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA., Pilar A; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Canada; Department of Radiation Oncology, University of Toronto, Toronto, Canada., Reddy C; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Wedde TB; Oslo University Hospital, Oslo, Norway., Lilleby WA; Oslo University Hospital, Oslo, Norway., Fiano R; Schiffler Cancer Center, Wheeling Hospital, Wheeling Jesuit University, Wheeling, WV, USA., Merrick GS; Schiffler Cancer Center, Wheeling Hospital, Wheeling Jesuit University, Wheeling, WV, USA., Stock RG; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Demanes DJ; California Endocurietherapy Cancer Center, Oakland, CA, USA., Moran BJ; Chicago Prostate Cancer Center, Westmont, IL, USA., Braccioforte M; Chicago Prostate Cancer Center, Westmont, IL, USA., Tran PT; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Martin S; Department of Radiation Oncology, Clínica Universidad de Navarra and Program in Solid Tumors, CIMA- University of Navarra, Pamplona, Spain., Martinez-Monge R; Department of Radiation Oncology, Clínica Universidad de Navarra and Program in Solid Tumors, CIMA- University of Navarra, Pamplona, Spain., Krauss DJ; Oakland University William Beaumont School of Medicine, Royal Oak, MI, USA., Abu-Isa EI; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA., Valle L; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA., Chong N; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA., Pisansky TM; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA., Choo CR; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA., Song DY; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Greco S; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Deville C; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., McNutt T; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., DeWeese TL; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Ross AE; Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Ciezki JP; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Tilki D; Department of Urology and Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Karnes RJ; Department of Urology, Mayo Clinic, Rochester, MN, USA., Klein EA; Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA., Tosoian JJ; Department of Urology, The James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Boutros PC; Department of Urology, University of California Los Angeles, Los Angeles, CA, USA., Nickols NG; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA; Department of Radiation Oncology, West Los Angeles Veterans Health Administration, Los Angeles, CA, USA., Bhat P; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Shabsovich D; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Juarez JE; David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA., Kupelian PA; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA., Rettig MB; Department of Medical Oncology, University of California Los Angeles, Los Angeles, CA, USA; Department of Medical Oncology, West Los Angeles Veterans Health Administration, Los Angeles, CA, USA., Berlin A; Radiation Medicine Program, Princess Margaret Cancer Centre, Toronto, Canada., Tward JD; Department of Radiotherapy Oncology, Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT, USA., Davis BJ; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA., Reiter RE; Department of Urology, University of California Los Angeles, Los Angeles, CA, USA., Steinberg ML; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA., Elashoff D; UCLA Division of General Internal Medicine and Health Services Research, Los Angeles, CA, USA., Horwitz EM; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA., Tendulkar RD; Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Kishan AU; Department of Radiation Oncology, University of California Los Angeles, Los Angeles, CA, USA; Department of Urology, University of California Los Angeles, Los Angeles, CA, USA. Electronic address: aukishan@mednet.ucla.edu.
Source: European urology [Eur Urol] 2021 Aug; Vol. 80 (2), pp. 142-146. Date of Electronic Publication: 2021 May 10.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Science Country of Publication: Switzerland NLM ID: 7512719 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-7560 (Electronic) Linking ISSN: 03022838 NLM ISO Abbreviation: Eur Urol Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first